By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Prothena Corporation plc 

25-28 North Wall Quay

  Dublin  1  Ireland
Phone: 353-1-902-3519 Fax: 353-1-902-3510



Company News
Prothena (PRTA) Announces Initiation Of Phase II PASADENA Study Of PRX002/RG7935 In Patients With Early Parkinson’s Disease 7/6/2017 12:56:57 PM
Prothena (PRTA) Announces Appointment Of Wagner Zago, PhD As Chief Scientific Officer 6/12/2017 11:21:05 AM
Prothena (PRTA) Announces Appointment Of Sarah Noonberg, MD, PhD As Chief Medical Officer 5/17/2017 11:15:35 AM
Prothena (PRTA) Reports First Quarter 2017 Financial Results And Provides R&D Update 5/10/2017 11:16:14 AM
Prothena (PRTA) To Report First Quarter 2017 Financial Results On May 9 5/3/2017 10:42:17 AM
Clinical Results Presented From Prothena (PRTA)’s Phase Ib Study Of PRX002/RG7935 Demonstrating Robust Antibody CNS Penetration And Significant Reduction Of Free Serum Alpha-Synuclein In Patients With Parkinson’s Disease 4/3/2017 7:42:54 AM
Prothena (PRTA) Announces President And CEO Dr. Dale B. Schenk To Take Medical Leave 9/27/2016 7:24:49 AM
Prothena (PRTA) Presents First Clinical Data for PRX003 for the Treatment of Inflammatory Diseases 6/10/2016 12:25:46 PM
Prothena (PRTA) Announces Appointment Of Chief Commercial Officer 2/25/2016 10:02:48 AM
Three Companies That Are Just as Great as Gilead (GILD) 2/4/2016 6:37:02 AM